Targeted treatment of autoimmune cytopenias in primary immunodeficiencies

Primary Immunodeficiencies (PID) are a group of rare congenital disorders of the immune system. Autoimmune cytopenia (AIC) represents the most common autoimmune manifestation in PID patients. Treatment of AIC in PID patients can be really challenging, since they are often chronic, relapsing and refr...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Lucia Pacillo, Giuliana Giardino, Donato Amodio, Carmela Giancotta, Beatrice Rivalta, Gioacchino Andrea Rotulo, Emma Concetta Manno, Cristina Cifaldi, Giuseppe Palumbo, Claudio Pignata, Paolo Palma, Paolo Rossi, Andrea Finocchi, Caterina Cancrini
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Subjects:	primary immunodeficiency inborn errors of immunity autoimmune cytopenia targeted therapy immune dysregulation
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.911385/full